Company / Revenue per Share
ABEONA THERAPEUTICS INC. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.13
FY2025
5-year range
$0.08 / $0.51
FY2021-FY2025
Trend
-3.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $0.02 in FY2019 to $0.51 in FY2022.
Based on SEC 10-K filings.
0.13 in FY2025 with a 5-year CAGR of +1.3%.
Improved from $0.08 to $0.13 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -37.0%
- 5-Year CAGR
- +1.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 3.4% year-over-year.
- Peak revenue per share was recorded in FY2022.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | -3.4% |
| FY2024 | $0.13 | +65.4% |
| FY2023 | $0.08 | -84.3% |
| FY2022 | $0.51 | +389.8% |
| FY2021 | $0.10 | -13.0% |
| FY2020 | $0.12 | +585.0% |
| FY2019 | $0.02 | -72.7% |
| FY2018 | $0.06 | +207.5% |
| FY2017 | $0.02 | -44.8% |
| FY2016 | $0.04 | -92.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026